Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Atsushi Mizokami

Showing results (1-10 of 406) with videos related to

Pageof 41
Sort By:
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[New inhibitors of adrenal androgen synthesis enzymes]Atsushi Mizokami
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2003
[Mechanisms of prostate cancer recurrence]Atsushi Mizokami, Mikio Namiki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Androgen receptor mutation]Atsushi Mizokami, Mikio Namiki
International Journal of Urology : Official Journal of the Japanese Urological Association|October 24, 2017
Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargementKazuyoshi Shigehara, Atsushi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Total androgen blockade]Mikio Namiki, Atsushi Mizokami
The Journal of Steroid Biochemistry and Molecular Biology|April 11, 2014
Reconsideration of progression to CRPC during androgen deprivation therapyAtsushi Mizokami, Mikio Namiki
Journal of Clinical Medicine|March 16, 2019
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer CellsKouji Izumi, Atsushi Mizokami
Clinical Calcium|February 2, 2010
[Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer]Kouji Izumi, Atsushi Mizokami, Mikio Namiki
Prostate International|November 14, 2013
Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screeningYasuhide Kitagawa, Atsushi Mizokami, Mikio Namiki
International Journal of Urology : Official Journal of the Japanese Urological Association|September 18, 2025
Durable Responses With Immune Checkpoint Inhibitors in the DANUBE TrialRyunosuke Nakagawa, Kouji Izumi, Atsushi Mizokami
Pageof 41

Showing results (1-10 of 406) with videos related to

Sort By:
Pageof 41
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2014
[New inhibitors of adrenal androgen synthesis enzymes]Atsushi Mizokami
Hinyokika Kiyo. Acta Urologica Japonica|January 7, 2003
[Mechanisms of prostate cancer recurrence]Atsushi Mizokami, Mikio Namiki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 3, 2012
[Androgen receptor mutation]Atsushi Mizokami, Mikio Namiki
International Journal of Urology : Official Journal of the Japanese Urological Association|October 24, 2017
Editorial Comment to Influence of dutasteride treatment on serum hormone levels and aging male symptoms in patients with benign prostatic enlargementKazuyoshi Shigehara, Atsushi Mizokami
Nihon Rinsho. Japanese Journal of Clinical Medicine|February 26, 2003
[Total androgen blockade]Mikio Namiki, Atsushi Mizokami
The Journal of Steroid Biochemistry and Molecular Biology|April 11, 2014
Reconsideration of progression to CRPC during androgen deprivation therapyAtsushi Mizokami, Mikio Namiki
Journal of Clinical Medicine|March 16, 2019
Suppressive Role of Androgen/Androgen Receptor Signaling via Chemokines on Prostate Cancer CellsKouji Izumi, Atsushi Mizokami
Clinical Calcium|February 2, 2010
[Bone and Men's Health. Hormonal therapy and bone loss in prostate cancer]Kouji Izumi, Atsushi Mizokami, Mikio Namiki
Prostate International|November 14, 2013
Trends of clinical symptoms and prognosis of middle-aged prostate cancer patients after instigation of prostate specific antigen-based population screeningYasuhide Kitagawa, Atsushi Mizokami, Mikio Namiki
International Journal of Urology : Official Journal of the Japanese Urological Association|September 18, 2025
Durable Responses With Immune Checkpoint Inhibitors in the DANUBE TrialRyunosuke Nakagawa, Kouji Izumi, Atsushi Mizokami
Pageof 41